HELX Earnings
Latest Revenue170.7M
Latest Net Income7.9M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q4 2019 | $0.06 | 170.7M | 7.9M | +7.8% | +160.0% |
| Q3 2019 | $0.21 | 212.6M | 31.6M | +0.0% | +16.7% |
| Q2 2019 | $0.11 | 201.7M | 16.8M | -1.4% | -8.3% |
| Q1 2019 | $0.01 | 166.8M | 1.3M | +1.6% | +150.0% |
| Q4 2018 | -$0.10 | 158.4M | -13747000 | -3.0% | -129.4% |
| Q3 2018 | $0.18 | 212.6M | 27.1M | +30.2% | +800.0% |
| Q2 2018 | $0.12 | 204.6M | 17.8M | +36.1% | +400.0% |
| Q1 2018 | -$0.02 | 164.3M | -2560000 | +57.1% | +81.8% |
| Q4 2017 | $0.34 | 163.3M | 50.6M | — | — |
| Q3 2017 | $0.02 | 163.3M | 2.3M | — | — |
| Q2 2017 | -$0.04 | 150.3M | -6403000 | — | — |
| Q1 2017 | -$0.11 | 104.5M | -16415000 | — | — |
Franklin Genomic Advancements ETF (HELX) — Earnings